AMR Action Fund

AMR Action Fund is the world's largest venture capital fund dedicated to investing in urgently needed antimicrobial therapeutics to combat antimicrobial resistance (AMR). The fund invests in biotechnology companies developing treatments for life-threatening antimicrobial-resistant infections, aiming to launch two to four new antibiotics by 2030. It builds partnerships to create a sustainable innovation ecosystem and advocates for market reforms to improve how society values lifesaving drugs. The fund emphasizes appropriate use and access principles to ensure new antibiotics are used responsibly and accessible globally, particularly in low- and middle-income countries. Its team comprises experts in venture capital, pharmaceutical development, finance, and health policy, leveraging their expertise to drive global change against AMR.